(VXF) Vanguard Extended Market - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US9229086528 • Mid-Cap Blend

VXF: Stocks, Small, Mid-size, U.S., Companies

The Vanguard Extended Market Index Fund ETF Shares (VXF) is designed to capture the performance of the S&P Completion Index, which includes small and mid-sized U.S. companies. This fund is a cost-effective way to gain exposure to a broad swath of the U.S. equity market, excluding the largest companies that are typically represented in the S&P 500. By targeting smaller-cap firms, VXF provides diversification beyond the mega-caps that dominate most portfolios.

The fund uses a sampling strategy to replicate the S&P Completion Index, meaning it doesn’t hold every single security in the index but selects a representative sample that mirrors the index’s key characteristics. This approach helps keep costs low while maintaining close tracking accuracy. The portfolio is diversified across various industries and market capitalization ranges, ensuring that it reflects the broader small and mid-cap market. Additionally, VXF’s portfolio is periodically rebalanced to maintain alignment with its target index.

With an AUM of over $22.5 billion, VXF is one of the largest ETFs in its category. It focuses on mid-cap blend stocks, meaning it includes companies that are neither growth nor value-oriented but fall somewhere in between. The fund’s structure allows it to provide exposure to a segment of the market that is often overlooked by investors who focus heavily on large-cap stocks. Historically, small and mid-cap companies have offered higher growth potential compared to their larger counterparts, though they also come with higher volatility.

For investors and fund managers, VXF is a useful tool for completing equity exposure beyond the S&P 500. It is domiciled in the United States and trades on the NYSE ARCA under the ticker symbol VXF. The fund’s low expense ratio and passive management approach make it an attractive option for those seeking efficient, low-cost access to the small and mid-cap segment of the U.S. equity market. It is particularly suitable for long-term investors looking to diversify their portfolios and capitalize on the growth potential of smaller companies.

Additional Sources for VXF ETF

VXF ETF Overview

Market Cap in USD 21,363m
Category Mid-Cap Blend
TER 0.06%
IPO / Inception 2001-12-27

VXF ETF Ratings

Growth 5y 56.4%
Fundamental -
Dividend 46.5%
Rel. Strength Industry -7.29
Analysts -
Fair Price Momentum 149.66 USD
Fair Price DCF -

VXF Dividends

Dividend Yield 12m 1.16%
Yield on Cost 5y 2.15%
Annual Growth 5y 3.28%
Payout Consistency 95.7%

VXF Growth Ratios

Growth Correlation 3m -44.5%
Growth Correlation 12m 85%
Growth Correlation 5y 42.3%
CAGR 5y 13.09%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m 0.94
Alpha -10.46
Beta 1.24
Volatility 23.90%
Current Volume 567.4k
Average Volume 20d 398.1k
What is the price of VXF stocks?
As of March 09, 2025, the stock is trading at USD 178.94 with a total of 567,432 shares traded.
Over the past week, the price has changed by -4.73%, over one month by -9.99%, over three months by -11.92% and over the past year by +5.04%.
Is Vanguard Extended Market a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Vanguard Extended Market (NYSE ARCA:VXF) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.43 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VXF as of March 2025 is 149.66. This means that VXF is currently overvalued and has a potential downside of -16.36%.
Is VXF a buy, sell or hold?
Vanguard Extended Market has no consensus analysts rating.
What are the forecast for VXF stock price target?
According to ValueRays Forecast Model, VXF Vanguard Extended Market will be worth about 177.7 in March 2026. The stock is currently trading at 178.94. This means that the stock has a potential downside of -0.72%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 177.7 -0.7%